Don S. Dizon, MD

Don S. Dizon, MD, FACP, FASCO, discusses future directions for precision medicine approaches in ovarian cancer.

Don S. Dizon, MD, on the prevalence of sexual complications in patients with breast cancer.

It is important that clinicians engage with social media, since reputations are at risk by not knowing what is being said, shared, and discussed online about them online.

Don S. Dizon, MD, Assistant in Medicine, Medical Gynecologic Oncology, Massachusetts General Hospital, explains the relationship between PTEN mutations and mTOR inhibitors in endometrial cancer.

I have just returned from the 21st Interdisciplinary Conference of the National Consortium of Breast Centers

In the United States, gynecologic cancers affect nearly 80,000 women annually and are the cause of death in more than 25,000 women.